Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-005119

Chief Medical Officer sold 4,846 shares at $12.01 ($58,200)

  • Chief Medical Officer acquired 8,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Solomons Neil · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-02 Grant or award : show line 1 in the form +8,500 95,799 D
2022-03-02 Sale : show line 2 in the form −4,846 $12.01 $58,200 90,953 D
Open-market sales · 4,846 sh · avg $12.01 · $58,200

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-02 Grant or award : show line 3 in the form Restricted Stock Unit +72,856 72,856 D
2022-03-02 Grant or award : show line 4 in the form Stock Option (right to buy) +124,644 124,644 D
Loading xslF345X03/wf-form4_164642821472438.xml…